Hoppenot Herve (CIK 1596492) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-01-06). Recent activity: Buy BCYC (3,032 shares), Sell INCY (2,843 shares), Sell INCY (187,500 shares), Buy BCYC (12,500 shares), Sell INCY (4,961 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | Director | Buy | 3,032 | $0 |
| 2025-12-10 | INCYTE CORP (INCY) | Director | Sell | 2,843 | $274,918 |
| 2025-11-12 | INCYTE CORP (INCY) | Director | Sell | 187,500 | $19.8M |
| 2025-09-10 | BICYCLE THERAPEUTICS PLC (BCYC) | Director | Buy | 12,500 | $0 |
| 2025-07-16 | INCYTE CORP (INCY) | Special Advisor to the CEO | Sell | 4,961 | $347,171 |
| 2025-07-16 | INCYTE CORP (INCY) | Special Advisor to the CEO | Sell | 4,713 | $321,662 |
| 2025-07-07 | INCYTE CORP (INCY) | Special Advisor to the CEO | Sell | 42,769 | $2.9M |
| 2025-06-30 | INCYTE CORP (INCY) | Special Advisor to the CEO | Buy | 6,016 | $0 |
| 2025-04-03 | INCYTE CORP (INCY) | Chairman / CEO | Buy | 66,899 | $0 |
Source: SEC Form 4 filings · as of 2026-01-06